Next Generation Sequencing Market Size, Share and Growth Outlook 2026: By Product and Service (Consumables, Platforms / Instruments, Services), By Technology, By Workflow, By Application, By End-User, Companies to 2034.
The global Next Generation Sequencing Market size is forecast to increase from $15.18 Billion in 2026 to $40.64 Billion in 2034 at a CAGR of 13.1% between 2026 and 2034.
The Next Generation Sequencing market report provides detailed analysis and outlook of Next Generation Sequencing segments including By Product and Service (Consumables, Platforms / Instruments, Services ), By Technology (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing and Resequencing), By Workflow (Pre-Sequencing, Sequencing, Data Analysis / Post-Sequencing Bioinformatics ), By Application (Oncology (Diagnostics, Screening, and Research), Clinical Investigation and Infectious Diseases, Reproductive Health (Non-Invasive Prenatal Testing (NIPT) and Preimplantation Genetic Testing), HLA Typing and Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Agrigenomics and Forensics, Consumer Genomics), By End-User (Academic Research Institutes, Clinical Research Organizations and Diagnostics Labs, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Next Generation Sequencing (NGS) Industry Overview
Genomic Research and Precision Medicine Continue to Expand NGS Adoption
The next generation sequencing industry remains one of the fastest-evolving segments of molecular biology, precision medicine, and clinical diagnostics. NGS technologies have transformed the ability to analyze genomes, transcriptomes, epigenomes, and complex molecular signatures at unprecedented scale and resolution. Applications now span oncology, rare disease diagnosis, reproductive health, infectious disease surveillance, pharmacogenomics, newborn screening, population genomics, and translational research. Continuous improvements in sequencing chemistry, bioinformatics, automation, data processing, and cloud-based analytics are enabling researchers and clinicians to generate deeper biological insights while improving workflow efficiency. As healthcare systems increasingly embrace precision medicine, NGS platforms are becoming essential tools for identifying disease mechanisms, detecting actionable biomarkers, and guiding personalized therapeutic strategies.
Whole-Genome Sequencing and Liquid Biopsy Applications Drive Clinical Innovation
Clinical adoption of next generation sequencing is accelerating as laboratories move beyond targeted panels toward more comprehensive genomic analysis. Tempus AI expanded this trend through the introduction of the xH assay, a whole-genome sequencing-based test designed to identify actionable cancer-associated genomic alterations from peripheral blood samples. The growing use of whole-genome sequencing within liquid biopsy workflows reflects increasing demand for broader genomic coverage capable of detecting variants that may not be captured by conventional testing approaches. Healthcare providers are increasingly utilizing NGS technologies to support early cancer detection, treatment selection, disease monitoring, and precision oncology initiatives. These developments demonstrate how sequencing is transitioning from specialized research applications into routine clinical decision-making environments where comprehensive genomic information can directly influence patient care strategies.
Spatial Biology and Population Screening Expand the Scope of Sequencing Technologies
The NGS industry is also experiencing rapid expansion into emerging applications that extend beyond traditional DNA sequencing. Illumina strengthened its multiomics portfolio through the launch of the StrataMap Spatial Solution, an end-to-end spatial whole-transcriptome platform that enables unbiased profiling at single-cell resolution while preserving tissue architecture context. Integration with advanced analytical software supports efficient processing of large and complex spatial genomics datasets, reflecting growing demand for technologies that combine sequencing with spatial biology insights. At the same time, Helyx Industries entered the NGS market through a dedicated sequencing division and participation in a neonatal screening initiative designed to identify more than 400 metabolic disorders using advanced genomic workflows. These developments highlight the increasing role of NGS in population health, newborn screening, multiomics research, and high-resolution biological characterization, further expanding the clinical and research applications of genomic sequencing technologies.
Next Generation Sequencing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Next Generation Sequencing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc. (PacBio), Oxford Nanopore Technologies plc, Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd, BGI Group (MGI Tech Co., Ltd.), PerkinElmer, Inc. (Revvity, Inc.), Bio-Rad Laboratories, Inc.. The Next Generation Sequencing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Next Generation Sequencing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Next Generation Sequencing industry include- Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc. (PacBio), Oxford Nanopore Technologies plc, Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd, BGI Group (MGI Tech Co., Ltd.), PerkinElmer, Inc. (Revvity, Inc.), Bio-Rad Laboratories, Inc.. The Next Generation Sequencing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Next Generation Sequencing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Next Generation Sequencing market remains one of the strongest-performing segments in the country.
The US Next Generation Sequencing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Next Generation Sequencing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Next Generation Sequencing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Next Generation Sequencing markets
Canada's strong Next Generation Sequencing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Next Generation Sequencing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Next Generation Sequencing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Next Generation Sequencing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Next Generation Sequencing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Next Generation Sequencing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Next Generation Sequencing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Next Generation Sequencing sales through 2034
France Next Generation Sequencing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Next Generation Sequencing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Next Generation Sequencing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Next Generation Sequencing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Next Generation Sequencing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Next Generation Sequencing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Next Generation Sequencing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Next Generation Sequencing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Next Generation Sequencing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Next Generation Sequencing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Next Generation Sequencing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Next Generation Sequencing Market Segmentation
By Product and Service
Consumables
Platforms / Instruments
Services
By Technology
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Resequencing
By Workflow
Pre-Sequencing
Sequencing
Data Analysis / Post-Sequencing Bioinformatics
By Application
Oncology (Diagnostics, Screening, and Research)
Clinical Investigation and Infectious Diseases
Reproductive Health (Non-Invasive Prenatal Testing (NIPT) and Preimplantation Genetic Testing)
HLA Typing and Immune System Monitoring
Metagenomics, Epidemiology and Drug Development
Agrigenomics and Forensics
Consumer Genomics
By End-User
Academic Research Institutes
Clinical Research Organizations and Diagnostics Labs
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Leading Companies in Next Generation Sequencing Industry (2026)
Illumina, Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California, Inc. (PacBio)
Oxford Nanopore Technologies plc
Agilent Technologies, Inc.
QIAGEN N.V.
F. Hoffmann-La Roche Ltd
BGI Group (MGI Tech Co., Ltd.)
PerkinElmer, Inc. (Revvity, Inc.)
Bio-Rad Laboratories, Inc.
Countries Included
The Next Generation Sequencing market report provides detailed analysis and outlook of Next Generation Sequencing segments including By Product and Service (Consumables, Platforms / Instruments, Services ), By Technology (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing and Resequencing), By Workflow (Pre-Sequencing, Sequencing, Data Analysis / Post-Sequencing Bioinformatics ), By Application (Oncology (Diagnostics, Screening, and Research), Clinical Investigation and Infectious Diseases, Reproductive Health (Non-Invasive Prenatal Testing (NIPT) and Preimplantation Genetic Testing), HLA Typing and Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Agrigenomics and Forensics, Consumer Genomics), By End-User (Academic Research Institutes, Clinical Research Organizations and Diagnostics Labs, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Next Generation Sequencing (NGS) Industry Overview
Genomic Research and Precision Medicine Continue to Expand NGS Adoption
The next generation sequencing industry remains one of the fastest-evolving segments of molecular biology, precision medicine, and clinical diagnostics. NGS technologies have transformed the ability to analyze genomes, transcriptomes, epigenomes, and complex molecular signatures at unprecedented scale and resolution. Applications now span oncology, rare disease diagnosis, reproductive health, infectious disease surveillance, pharmacogenomics, newborn screening, population genomics, and translational research. Continuous improvements in sequencing chemistry, bioinformatics, automation, data processing, and cloud-based analytics are enabling researchers and clinicians to generate deeper biological insights while improving workflow efficiency. As healthcare systems increasingly embrace precision medicine, NGS platforms are becoming essential tools for identifying disease mechanisms, detecting actionable biomarkers, and guiding personalized therapeutic strategies.
Whole-Genome Sequencing and Liquid Biopsy Applications Drive Clinical Innovation
Clinical adoption of next generation sequencing is accelerating as laboratories move beyond targeted panels toward more comprehensive genomic analysis. Tempus AI expanded this trend through the introduction of the xH assay, a whole-genome sequencing-based test designed to identify actionable cancer-associated genomic alterations from peripheral blood samples. The growing use of whole-genome sequencing within liquid biopsy workflows reflects increasing demand for broader genomic coverage capable of detecting variants that may not be captured by conventional testing approaches. Healthcare providers are increasingly utilizing NGS technologies to support early cancer detection, treatment selection, disease monitoring, and precision oncology initiatives. These developments demonstrate how sequencing is transitioning from specialized research applications into routine clinical decision-making environments where comprehensive genomic information can directly influence patient care strategies.
Spatial Biology and Population Screening Expand the Scope of Sequencing Technologies
The NGS industry is also experiencing rapid expansion into emerging applications that extend beyond traditional DNA sequencing. Illumina strengthened its multiomics portfolio through the launch of the StrataMap Spatial Solution, an end-to-end spatial whole-transcriptome platform that enables unbiased profiling at single-cell resolution while preserving tissue architecture context. Integration with advanced analytical software supports efficient processing of large and complex spatial genomics datasets, reflecting growing demand for technologies that combine sequencing with spatial biology insights. At the same time, Helyx Industries entered the NGS market through a dedicated sequencing division and participation in a neonatal screening initiative designed to identify more than 400 metabolic disorders using advanced genomic workflows. These developments highlight the increasing role of NGS in population health, newborn screening, multiomics research, and high-resolution biological characterization, further expanding the clinical and research applications of genomic sequencing technologies.
Next Generation Sequencing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Next Generation Sequencing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc. (PacBio), Oxford Nanopore Technologies plc, Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd, BGI Group (MGI Tech Co., Ltd.), PerkinElmer, Inc. (Revvity, Inc.), Bio-Rad Laboratories, Inc.. The Next Generation Sequencing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Next Generation Sequencing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Next Generation Sequencing Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Next Generation Sequencing companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Next Generation Sequencing markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Next Generation Sequencing industry include- Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc. (PacBio), Oxford Nanopore Technologies plc, Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd, BGI Group (MGI Tech Co., Ltd.), PerkinElmer, Inc. (Revvity, Inc.), Bio-Rad Laboratories, Inc.. The Next Generation Sequencing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Next Generation Sequencing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Next Generation Sequencing market remains one of the strongest-performing segments in the country.
The US Next Generation Sequencing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Next Generation Sequencing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Next Generation Sequencing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Next Generation Sequencing markets
Canada's strong Next Generation Sequencing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Next Generation Sequencing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Next Generation Sequencing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Next Generation Sequencing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Next Generation Sequencing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Next Generation Sequencing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Next Generation Sequencing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Next Generation Sequencing sales through 2034
France Next Generation Sequencing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Next Generation Sequencing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Next Generation Sequencing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Next Generation Sequencing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Next Generation Sequencing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Next Generation Sequencing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Next Generation Sequencing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Next Generation Sequencing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Next Generation Sequencing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Next Generation Sequencing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Next Generation Sequencing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Next Generation Sequencing Market Segmentation
By Product and Service
Consumables
Platforms / Instruments
Services
By Technology
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Resequencing
By Workflow
Pre-Sequencing
Sequencing
Data Analysis / Post-Sequencing Bioinformatics
By Application
Oncology (Diagnostics, Screening, and Research)
Clinical Investigation and Infectious Diseases
Reproductive Health (Non-Invasive Prenatal Testing (NIPT) and Preimplantation Genetic Testing)
HLA Typing and Immune System Monitoring
Metagenomics, Epidemiology and Drug Development
Agrigenomics and Forensics
Consumer Genomics
By End-User
Academic Research Institutes
Clinical Research Organizations and Diagnostics Labs
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Leading Companies in Next Generation Sequencing Industry (2026)
Illumina, Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California, Inc. (PacBio)
Oxford Nanopore Technologies plc
Agilent Technologies, Inc.
QIAGEN N.V.
F. Hoffmann-La Roche Ltd
BGI Group (MGI Tech Co., Ltd.)
PerkinElmer, Inc. (Revvity, Inc.)
Bio-Rad Laboratories, Inc.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Next Generation Sequencing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Next Generation Sequencing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEXT GENERATION SEQUENCING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Next Generation Sequencing Markets in 2026
3.2. Global Historic and Forecast Next Generation Sequencing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Next Generation Sequencing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Next Generation Sequencing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Next Generation Sequencing Value Chain
CHAPTER 4- NEXT GENERATION SEQUENCING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Next Generation Sequencing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEXT GENERATION SEQUENCING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product and Service
Consumables
Platforms / Instruments
Services
By Technology
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Resequencing
By Workflow
Pre-Sequencing
Sequencing
Data Analysis / Post-Sequencing Bioinformatics
By Application
Oncology (Diagnostics, Screening, and Research)
Clinical Investigation and Infectious Diseases
Reproductive Health (Non-Invasive Prenatal Testing (NIPT) and Preimplantation Genetic Testing)
HLA Typing and Immune System Monitoring
Metagenomics, Epidemiology and Drug Development
Agrigenomics and Forensics
Consumer Genomics
By End-User
Academic Research Institutes
Clinical Research Organizations and Diagnostics Labs
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Next Generation Sequencing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Next Generation Sequencing Market Trends and Growth Opportunities to 2034
7.5. North America Next Generation Sequencing Market Size Outlook by Type
7.6. North America Next Generation Sequencing Market Size Outlook by Application
7.7. North America Next Generation Sequencing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Next Generation Sequencing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Next Generation Sequencing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Next Generation Sequencing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Next Generation Sequencing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Next Generation Sequencing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Next Generation Sequencing Companies
CHAPTER 8- EUROPE NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Next Generation Sequencing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Next Generation Sequencing Market Trends and Growth Opportunities to 2034
8.5. Europe Next Generation Sequencing Market Size Outlook by Type
8.6. Europe Next Generation Sequencing Market Size Outlook by Application
8.7. Europe Next Generation Sequencing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Next Generation Sequencing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Next Generation Sequencing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Next Generation Sequencing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Next Generation Sequencing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Next Generation Sequencing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Next Generation Sequencing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Next Generation Sequencing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Next Generation Sequencing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Next Generation Sequencing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Next Generation Sequencing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Next Generation Sequencing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Next Generation Sequencing Companies
CHAPTER 9- ASIA PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Next Generation Sequencing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Next Generation Sequencing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Next Generation Sequencing Market Size Outlook by Type
9.6. Asia Pacific Next Generation Sequencing Market Size Outlook by Application
9.7. Asia Pacific Next Generation Sequencing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Next Generation Sequencing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Next Generation Sequencing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Next Generation Sequencing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Next Generation Sequencing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Next Generation Sequencing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Next Generation Sequencing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Next Generation Sequencing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Next Generation Sequencing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Next Generation Sequencing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Next Generation Sequencing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Next Generation Sequencing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Next Generation Sequencing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Next Generation Sequencing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Next Generation Sequencing Market Trends and Growth Opportunities to 2034
10.5. South and Central America Next Generation Sequencing Market Size Outlook by Type
10.6. South and Central America Next Generation Sequencing Market Size Outlook by Application
10.7. South and Central America Next Generation Sequencing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Next Generation Sequencing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Next Generation Sequencing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Next Generation Sequencing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Next Generation Sequencing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Next Generation Sequencing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Next Generation Sequencing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Next Generation Sequencing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Next Generation Sequencing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Next Generation Sequencing Market Size Outlook by Type
11.6. Middle East and Africa Next Generation Sequencing Market Size Outlook by Application
11.7. Middle East and Africa Next Generation Sequencing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Next Generation Sequencing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Next Generation Sequencing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Next Generation Sequencing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Next Generation Sequencing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Next Generation Sequencing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Next Generation Sequencing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Next Generation Sequencing Industry
Illumina, Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California, Inc. (PacBio)
Oxford Nanopore Technologies plc
Agilent Technologies, Inc.
QIAGEN N.V.
F. Hoffmann-La Roche Ltd
BGI Group (MGI Tech Co., Ltd.)
PerkinElmer, Inc. (Revvity, Inc.)
Bio-Rad Laboratories, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Next Generation Sequencing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Next Generation Sequencing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEXT GENERATION SEQUENCING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Next Generation Sequencing Markets in 2026
3.2. Global Historic and Forecast Next Generation Sequencing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Next Generation Sequencing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Next Generation Sequencing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Next Generation Sequencing Value Chain
CHAPTER 4- NEXT GENERATION SEQUENCING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Next Generation Sequencing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEXT GENERATION SEQUENCING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product and Service
Consumables
Platforms / Instruments
Services
By Technology
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing and Resequencing
By Workflow
Pre-Sequencing
Sequencing
Data Analysis / Post-Sequencing Bioinformatics
By Application
Oncology (Diagnostics, Screening, and Research)
Clinical Investigation and Infectious Diseases
Reproductive Health (Non-Invasive Prenatal Testing (NIPT) and Preimplantation Genetic Testing)
HLA Typing and Immune System Monitoring
Metagenomics, Epidemiology and Drug Development
Agrigenomics and Forensics
Consumer Genomics
By End-User
Academic Research Institutes
Clinical Research Organizations and Diagnostics Labs
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Next Generation Sequencing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Next Generation Sequencing Market Trends and Growth Opportunities to 2034
7.5. North America Next Generation Sequencing Market Size Outlook by Type
7.6. North America Next Generation Sequencing Market Size Outlook by Application
7.7. North America Next Generation Sequencing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Next Generation Sequencing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Next Generation Sequencing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Next Generation Sequencing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Next Generation Sequencing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Next Generation Sequencing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Next Generation Sequencing Companies
CHAPTER 8- EUROPE NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Next Generation Sequencing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Next Generation Sequencing Market Trends and Growth Opportunities to 2034
8.5. Europe Next Generation Sequencing Market Size Outlook by Type
8.6. Europe Next Generation Sequencing Market Size Outlook by Application
8.7. Europe Next Generation Sequencing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Next Generation Sequencing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Next Generation Sequencing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Next Generation Sequencing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Next Generation Sequencing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Next Generation Sequencing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Next Generation Sequencing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Next Generation Sequencing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Next Generation Sequencing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Next Generation Sequencing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Next Generation Sequencing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Next Generation Sequencing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Next Generation Sequencing Companies
CHAPTER 9- ASIA PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Next Generation Sequencing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Next Generation Sequencing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Next Generation Sequencing Market Size Outlook by Type
9.6. Asia Pacific Next Generation Sequencing Market Size Outlook by Application
9.7. Asia Pacific Next Generation Sequencing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Next Generation Sequencing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Next Generation Sequencing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Next Generation Sequencing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Next Generation Sequencing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Next Generation Sequencing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Next Generation Sequencing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Next Generation Sequencing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Next Generation Sequencing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Next Generation Sequencing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Next Generation Sequencing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Next Generation Sequencing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Next Generation Sequencing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Next Generation Sequencing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Next Generation Sequencing Market Trends and Growth Opportunities to 2034
10.5. South and Central America Next Generation Sequencing Market Size Outlook by Type
10.6. South and Central America Next Generation Sequencing Market Size Outlook by Application
10.7. South and Central America Next Generation Sequencing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Next Generation Sequencing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Next Generation Sequencing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Next Generation Sequencing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Next Generation Sequencing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Next Generation Sequencing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Next Generation Sequencing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Next Generation Sequencing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Next Generation Sequencing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Next Generation Sequencing Market Size Outlook by Type
11.6. Middle East and Africa Next Generation Sequencing Market Size Outlook by Application
11.7. Middle East and Africa Next Generation Sequencing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Next Generation Sequencing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Next Generation Sequencing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Next Generation Sequencing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Next Generation Sequencing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Next Generation Sequencing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Next Generation Sequencing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Next Generation Sequencing Industry
Illumina, Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California, Inc. (PacBio)
Oxford Nanopore Technologies plc
Agilent Technologies, Inc.
QIAGEN N.V.
F. Hoffmann-La Roche Ltd
BGI Group (MGI Tech Co., Ltd.)
PerkinElmer, Inc. (Revvity, Inc.)
Bio-Rad Laboratories, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
